Pioglitazone: European approval maintained despite the acknowledged risks.
出版信息
Prescrire Int. 2012 Jul;21(129):181.
PMID:22852286
Abstract
摘要
相似文献
1
Pioglitazone: European approval maintained despite the acknowledged risks.吡格列酮：尽管存在已知风险，但仍维持在欧洲的批准状态。
Prescrire Int. 2012 Jul;21(129):181.
2
Meta-analysis confirms raised risk of bladder cancer from pioglitazone.荟萃分析证实吡格列酮会增加患膀胱癌的风险。
BMJ. 2012 Jul 4;345:e4541. doi: 10.1136/bmj.e4541.
3
Pioglitazone and bladder cancer: the pros and cons.吡格列酮与膀胱癌：利弊分析
J Assoc Physicians India. 2012 Jan;60:72-3.
4
Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes.吡格列酮可能与日本 2 型糖尿病患者的膀胱癌有关。
Diabetes Res Clin Pract. 2013 Feb;99(2):e21-3. doi: 10.1016/j.diabres.2012.11.013. Epub 2012 Dec 7.
5
Eight cases of bladder cancer in pioglitazone users from India.来自印度的吡格列酮使用者中有8例膀胱癌病例。
J Assoc Physicians India. 2012 Dec;60:66.
6
Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis.吡格列酮治疗糖尿病患者膀胱癌风险增加：一项荟萃分析。
Diabetes Res Clin Pract. 2012 Oct;98(1):159-63. doi: 10.1016/j.diabres.2012.05.006. Epub 2012 Jun 16.
7
The cage in search of a bird.寻觅鸟儿的牢笼。
J Assoc Physicians India. 2012 Jan;60:74-5.
8
Balancing the risks and benefits for pioglitazone in type 2 diabetes.权衡吡格列酮在2型糖尿病治疗中的风险与获益
Diabetes Res Clin Pract. 2012 Oct;98(1):1-2. doi: 10.1016/j.diabres.2012.08.005. Epub 2012 Sep 7.
9
Pioglitazone and the risk of bladder cancer.吡格列酮与膀胱癌风险
BMJ. 2012 May 30;344:e3500. doi: 10.1136/bmj.e3500.
10
Updated Review Confirms Potential Risk of Bladder Cancer with Pioglitazone.最新综述证实吡格列酮存在膀胱癌潜在风险。
Am J Nurs. 2017 Apr;117(4):25. doi: 10.1097/01.NAJ.0000515230.35655.54.
Zotero 插件